New Treatment Addressing the Pathogenesis of Psoriasis

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1IL-17 and IL-22 enhance skin inflammation by stimulating the secretion of IL-1β by keratinocytes via the ROS-NLRP3-caspase-1 pathway2011 · 143 citations
2. 22-Imino-thiazolidin-4-one Derivatives as Potent, Orally Active S1P1Receptor Agonists2010 · 179 citations
3. 3Selective<scp>ROCK</scp>2 inhibition in focal cerebral ischemia2013 · 124 citations
4. 4Autoantigens <scp>ADAMTSL</scp>5 and <scp>LL</scp>37 are significantly upregulated in active Psoriasis and localized with keratinocytes, dendritic cells and other leukocytes2017 · 122 citations
5. 5Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study2012 · 334 citations